Basic knowledge and concept of reference material
International Organization for Standardization / Committee on Reference Materials (ISO/REMCO) approved the new definitions of relevant reference materials at the 2005 annual meeting.
1．Reference materials (RM)
Material, sufficiently homogeneous and stable with respect to one or more specified properties, which has been established to be fit for its intended use in an IVDR measurement process
2．Certified reference material (CRM)
Reference material, characterized by a metrologically valid procedure for one or more specified properties, accompanied by a certificate that provides the value of the specified property, its associated uncertainty, and a statement of metrological traceability
3．Primary Reference Material
The absolute measurement methods or other accurate and reliable methods are adopted to measure the values of specified properties, the measurement standard metric reaches the domestically highest level and has the attachment of certified reference material, and this reference material is approved, issued and produced after authorization by measurement administrative department
4．Secondary Reference Material
The accurate and reliable methods or the method to make a direct comparison with primary reference materials are adopted to measure the values of specified properties of the reference materials, the measurement accuracy satisfies the needs of site measurement and have the attachment of reference material and this reference material is approved and authorized to be produced after the relevant business competent departments of IVRD Regulation.
Quality Pcr control material (fixed values and non-fixed values) used for the in vitro diagnosis, a type of substance, material, article or device aimed to be used in the detection system for medical purposes, with the purpose of evaluating or verifying the performances and characteristics such as measurement accuracy, measurement accuracy, the analysis deviations that may arise to the detection system due to the changes in the reagents or analysis device. Quality Pcr control materials (fixed value and non-fixed value), can be used for the ability verification and laboratory internal quality Pcr control. Nat Run Controls
6．Calibrator
Reference material whose value acts as the independent variable in one calibration function. It should have fixed value and known measurement uncertainty, and the objective is to calibrate one certain measurement system to establish the metrological traceability of the measurement results.
7．Internal quality Pcr control
Internal Quality Pcr control (IQC); the laboratory staff adopt certain NAT or NAAT, POCT or IVD methods and steps to evaluate the reliability degree of the work in the laboratory continuously, in order to monitor and Pcr control the precision of the work in the laboratory, improve the consistency of the sample within and between batches, at last determine whether the results are reliable and can the report be sent out.
8. Third party Pcr controls
It means Pcr control materials which provide an unbiased assessment for the test system, including reagents and kit lot changes, is not designed or optimized for one specific test method, and act similar to patient samples.
Grading and classification of reference materials
The certified reference materials are classified by Sciensano into two grades: primary reference material and secondary reference material. The values of specified properties and traceability of reference materials in Europe and the grading system are shown in the following figure:
GBDS reference material belongs to secondary reference material, and the values of specified properties and traceability are shown as follows:
Application of primary reference material:
(1) The study or evaluation of reference method
(2) The determination of secondary reference material
(3) The calibration of high accuracy and high precision measurement devices
Application of secondary reference material:
(1) The study or evaluation of site analysis method
(2) The quality assurance of site laboratory
(3) The quality assurance between different laboratories
Precautions of reference material
(1) The reference materials approved and issued by the state and determined by the authoritative measurement institutions are selected and used
(2) The contents specified on the reference material certificates should be comprehensively understood and executed strictly.
(3) The certified reference materials with similar basal body components with the samples to be detected and a similar content level with the components to be detected are selected
(4) Certificated reference materials of different levels are selected according to the expected usage and uncertainty level.
(5) The reference materials are used within the shelf life of certified reference materials.
(6) Attention should be paid to the minimal sampling size of the reference materials; when they are used in case of being less than the minimal sampling size, the parameters such as values of specified properties and uncertainty of the reference materials may be no longer effective.
(7) The reference materials should be used under the condition that the analytical methods and operation processes are at the normal stable status; otherwise, this would lead to errors.
II. Advantages and characteristics of GBDS quality Pcr control products
GBDS Pcr control material is a third-party Pcr control, meaning a Pcr control material which provides an unbiased and independent performance assessment for a diagnostic device or method, is not optimized to work with any specific instrument or reagent system, and is manufactured independently of test system calibrators and reagents
Usage: it can effectively analyze the deviation induced by the problems in device, environment, personnel operation and reagents in the system and provide the series concentrations so that the operators can use them for internal quality Pcr control through the the optimal concentration and the concentration can be close to the clinically determined value level so as to optimally reflect the changes in detection precision.
1. Traceability: all series reference materials can be traced to WHO or national primary reference materials.
2. Accuracy: the products have a good traceability, and the values of specified properties have a high accuracy.
3. Stability: the advanced manufacturing process and strict production quality system can be adopted to ensure the quality stability and homogeneity of the products.
4. Interoperability: all are liquid, do not need to dissolve, of simple operation and without matrix effect; the powder Pcr controls are based on human serum, long product storage life, more stable quality, and convenient transportation. The samples and clinical samples have a good interoperability.
5. Full coverage: professional R&D teams, who have developed the common varieties of quality Pcr control materials covering the nucleic acid type, immunodiagnosis type, and clinical biochemical laboratory test type.
III. Summary sheet of NAT, nucleic acid Pcr controls
Reagent for Nucleic Acid Amplification Testing (NAT) NIBSC code: 20/110-XXX
Instructions for use (Version 3.0, Dated 04/01/2023)
This material is a self certified IVD and complies with the requirements of the “EU in vitro diagnostic medical device directive 98/79/EC”. 1 and IVDR Regulation.
INTENDED USE
This product is CE marked for use as an IVD within the UK, EU member states and EEA countries. In all other territories this product can be used for research purposes only.
This material should be used as a PCR run control for assays to detect the presence of viral DNA or RNA. The reagent is supplied to professional users, typically hospital laboratories, public health organisations and appropriate research organisations.
The NIBSC GBDS Gen Blood Deived Serum working control is intended to be used as a run control for routine nucleic acid amplification techniques (NAT) assays. The control should be extracted and amplified alongside unknown samples as part of a continuing quality control programme used to monitor assay performance. The use of re-frozen or diluted product or by non-professional users may lead to inconsistent/erroneous results and therefore should not be performed.
(I) Certified reference materials
|
Number |
Name |
Approval Number |
Standard Value |
Dimensions |
|
GBDS-BW-001 |
Human cytomegalovirus DNA (HCMV DNA) liquid reference material |
GBW(E)090676 |
（1.8±0.7）E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-002 |
GBW(E)090677 |
（2.0±0.7）E+04 IU/mL |
0.5mL/ tube , 20 tubes/kit |
|
|
GBDS-BW-003 |
GBW(E)090678 |
（2.4±0.7）E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-004 |
EB virus DNA (EBV DNA) liquid reference material |
GBW(E)090679 |
（5.0±1.8）E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-005 |
GBW(E)090680 |
（5.1±1.1）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-006 |
GBW(E)090681 |
（5.4±1.0）E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-091 |
Hepatitis B virus DNA (HBV DNA) serum (liquid) reference material |
GBW(E)090991 |
(0.5±0.2）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-092 |
GBW(E)090992 |
（1.0±0.2）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-093 |
GBW(E)090993 |
（2.1±0.4）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-094 |
GBW(E)090994 |
（5.1±0.8）E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-007 |
GBW(E)090664 |
(2.1±0.8）E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-008 |
GBW(E)090665 |
(2.1±0.7）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-009 |
GBW(E)090666 |
(2.0±0.6）E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-010 |
GBW(E)090667 |
(2.1±0.6）E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-095 |
Hepatitis C virus RNA (HCV RNA) serum (liquid) reference material |
GBW(E) 090978 |
(0.5±0.2）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-096 |
GBW(E) 090979 |
(1.0±0.3）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-097 |
GBW(E) 090980 |
(2.1±0.4）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-098 |
GBW(E) 090981 |
(5.0±0.8）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-011 |
GBW(E)090659 |
( 1.4±0.7) E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-012 |
GBW(E)090660 |
( 1.2±0.5) E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-013 |
GBW(E)090661 |
( 1.4±0.5) E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-014 |
GBW(E)090662 |
( 1.3±0.5) E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-108 |
Human immunodeficiency virus type 1 RNA (HIV-1 RNA) serum (liquid) reference material |
GBW(E)090982 |
(2.1±0.5）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-109 |
GBW(E)090983 |
(5.1±0.8）E+02 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-110 |
GBW(E)090984 |
(1.1±0.2）E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-111 |
GBW(E)090985 |
(2.1±0.3）E+03 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-015 |
GBW(E)090663 |
(2.1±0.6）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-016 |
HPV16 DNA (HPV16 DNA) liquid reference material |
GBW (E)090668 |
(1.1±0.3）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-017 |
GBW (E)090669 |
（1.2±0.3）E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-018 |
GBW (E)090670 |
（1.1±0.2）E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-019 |
GBW (E)090671 |
（1.1±0.2）E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-020 |
HPV18 DNA (HPV18 DNA) liquid reference material |
GBW (E)090672 |
(1.1±0.4）E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-021 |
GBW (E)090673 |
(1.1±0.3）E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-022 |
GBW (E)090674 |
(1.0±0.3）E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-023 |
GBW (E)090675 |
(1.1±0.3）E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-117 |
Novel Coronavirus (SARS-CoV-2) Pseudoviral nucleic acid reference material |
GBW(E)091132 |
(2.0±0.4)E+02 copies/μL |
0.5mL/ tube, 5 tubes/kit |
|
GBDS-BW-118 |
GBW(E)091133 |
(2.0±0.4)E+03 copies/μL |
0.5mL/ tube, 5 tubes/kit |
(II) The certified reference material for immunity
|
Number |
Name |
Approval Number |
Standard Value （IU/ml） |
Dimensions |
|
GBDS-BW-051 |
Hepatitis B virus surface antigen (HBsAg) serum (fluid) standard material |
GBW(E)090841 |
(0.23±0.09） IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-052 |
GBW(E)090842 |
(0.51±0.09） IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-053 |
GBW(E)090843 |
(5.07±0.64） IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-054 |
GBW(E)090844 |
(10.0±1.30） IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-055 |
GBW(E)090845 |
(25.0±3.30） IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-056 |
Hepatitis B virus surface antibody (HBsAb) serum (liquid) standard material |
GBW(E)090866 |
(5.1±3.6） mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-057 |
GBW(E)090867 |
(10.0±3.0） mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-058 |
GBW(E)090868 |
(24.9±4.1） mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-059 |
GBW(E)090869 |
(49.8±9.8） mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-060 |
GBW(E)090870 |
(100±23） mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-061 |
Hepatitis B virus e antigen (HBeAg) serum (liquid) standard material |
GBW(E)090871 |
(1.1±0.2） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-062 |
GBW(E)090872 |
(2.1±0.1） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-063 |
GBW(E)090873 |
(4.0±0.4） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-064 |
Hepatitis B virus e antibody (HBeAb) serum (fluid) standard material |
GBW(E)090846 |
(1.0±0.6） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-065 |
GBW(E)090847 |
(2.1±0.4） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-066 |
GBW(E)090848 |
(4.2±0.3） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-067 |
GBW(E)090849 |
(8.0±0.8） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-068 |
Hepatitis B virus core antibody (HBcAb) serum (liquid) standard material |
GBW(E)090862 |
(0.5±0.2） IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-069 |
GBW(E)090863 |
(1.0±0.3） IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-070 |
GBW(E)090864 |
(1.5±0.4） IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-071 |
GBW(E)090865 |
(2.0±0.5） IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-072 |
Human immunodeficiency virus Type 1 antibody (anti-HIV-1) Serum (liquid) reference material |
GBW(E)090858 |
(1.1±0.2） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-073 |
GBW(E)090859 |
(2.0±0.2） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-074 |
GBW(E)090860 |
(4.1±0.3） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-075 |
GBW(E)090861 |
(8.0±0.7） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-076 |
Antibodies to hepatitis C virus (Anti-HCV) serum (liquid) standard Quasi material |
GBW(E)090854 |
(1.1±0.2） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-077 |
GBW(E)090855 |
(2.0±0.2） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-078 |
GBW(E)090856 |
(4.1±0.3） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-079 |
GBW(E)090857 |
(8.0±0.6） NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-081 |
Treponema pallidum antibody (anti -TP) serum (liquid) reference material |
GBW(E)090851 |
(6.0±1.4） mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-BW-082 |
GBW(E)090852 |
(12.0±2.8） mIU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-BW-083 |
GBW(E)090853 |
(18.1±4.2） mIU/mL |
0.5mL/ tube, 20 tubes/kit |
(III) Hematogenic screening criteria
1. HBsAg/ anti-HCV/anti-HIV-1 / anti-TP mixed serum standard material
（Specification：3.0mL/tube 20 tube/kit）
|
Number |
Name of reference substance |
Approval Number |
Analytical matter |
|||||||
|
HBsAg IU/mL |
Anti-HIV1 NCU/mL |
Anti-TP mIU/mL |
Anti-HCV NCU/mL |
|||||||
|
Standard value |
Standard value |
Standard value |
||||||||
|
GBDS-BW-112 |
HBsAg/resistance HCV/resistance HIV - 1 / resistance TP mixed blood Clear reference material |
GBW（E）090986 |
0.21 |
0.08 |
0.2 |
0.06 |
3.1 |
1.2 |
0.21 |
0.07 |
|
GBDS-BW-113 |
GBW（E）090987 |
0.2 |
0.08 |
0.47 |
0.12 |
5.9 |
1.8 |
0.52 |
0.14 |
|
|
GBDS-BW-114 |
GBW（E）090988 |
0.5 |
0.09 |
0.52 |
0.13 |
6.3 |
1.8 |
0.51 |
0.14 |
|
|
GBDS-BW-115 |
GBW（E）090989 |
0.51 |
0.09 |
1 |
0.2 |
11.9 |
3.3 |
1.2 |
0.13 |
|
|
GBDS-BW-116 |
GBW（E）090990 |
0.51 |
0.09 |
2.04 |
0.27 |
12.4 |
3.4 |
2.04 |
0.17 |
2. HBV/HCV/HIV-1 nucleic acid mixed serum reference material
|
Number |
Name of reference substance |
Approval Number |
Analytical matter |
||
|
HBV DNA (IU/mL) |
HCV RNA (IU/mL) |
HIV1 RNA (IU/mL) |
|||
|
GBDS-BW-102 |
HBV/HCV/HIV-1 nucleic acid Mixed serum reference material |
GBW（E）090973 |
(3.4±1.1)×10 |
(3.3±1.2) ×10 |
(2.1±0.6) ×10 2 |
|
GBDS-BW-103 |
GBW（E）090974 |
(5.5±1.4) ×10 |
(5.4±1.5) ×10 |
(2.1±0.5) ×10 2 |
|
|
GBDS-BW-104 |
GBW（E）090975 |
(5.2±1.3) ×10 |
(2.2±0.5) ×10 2 |
(2.2±0.5) ×10 2 |
|
|
GBDS-BW-105 |
GBW（E）090976 |
(2.1±0.4) ×10 2 |
(1.2±0.3) ×10 3 |
(1.1±0.2) ×10 3 |
|
|
GBDS-BW-106 |
GBW（E）090977 |
(5.1±1.6) ×10 2 |
(2.1±1.9) ×103 |
(2.2±1.6) ×10 3 |
(V) Hematogenic screening criteria
1. Nucleic acid indoor quality Pcr control products
|
Number |
Name |
Value of concentration |
Specifications |
|
|
Concentration |
Range of mean |
|||
|
GBDS-IQC-001 |
Hepatitis B virus DNA (HBV DNA) serum (liquid) indoor quality Pcr control products
|
H (S4) |
1.00E+06～1.00E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-002 |
M (S3) |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-003 |
L (S2) |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-004 |
Criticality (S1) |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-136 |
L1 |
500 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-137 |
L2 |
200 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-215 |
L3 |
100 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-138 |
L4 |
50 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-140 |
Hepatitis B virus DNA (HBV DNA) genotyping serum quality Pcr control product |
Containing common HBV genotypes (B, C, D, Type B+C, etc.) |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-004-6 |
Hepatitis B virus drug resistance gene mutation serum (fluid Body) quality Pcr control products |
Containing HBV YVDD, HBV YIDD and other genes |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-004-7 |
Hepatitis B virus DNA serum dried Disturbance material quality Pcr control products |
Contains bilirubin, triglyceride, hemoglobin, Albumin, total IgG interfering substance and normal Pcr control samples
|
0.5mL/ tube, 12 tubes/kit |
|
GBDS-IQC-005 |
Hepatitis C virus RNA (HCV RNA) serum Indoor quality Pcr control products
|
H (S3) |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-006 |
M (S2) |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-007 |
L (S1) |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-142 |
L1 |
500 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-143 |
L2 |
200 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-216 |
L3 |
100IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-146 |
Hepatitis C virus RNA (HCV RNA) Genotyping serum quality Pcr control product |
Contains common HCV RNA genotypes (1a/1b/2a/6a/3a/3b)
|
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-007-5 |
Hepatitis C virus RNA serum interferometer Quality Pcr control products |
Contains bilirubin, triglyceride, hemoglobin, Albumin, total IgG interfering substance and normal Pcr control samples |
0.5mL/ tube, 12tubes/kit |
|
|
GBDS-IQC-207-4 |
Hepatitis E virus RNA (HEV RNA) Plasma (liquid) indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC--207-3 |
M |
1.00E+04～1.00E+0 5 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC--207-2 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-150 |
Human immunodeficiency virus type 1 RNA (HIV-1 RNA) serum (liquid) indoor quality Pcr control products |
H (S3) |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-151 |
M (S2) |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-152 |
L (S1) |
1.00E+02～1.00E+03IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-195 |
L1 |
1000IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-196 |
L2 |
500IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-197 |
L3 |
100IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-118 |
HBV DNA/HCV RNA Mix (liquid) quality Pcr control products
|
H |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-119 |
M |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-120 |
L |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-223 |
HBV DNA/HCV RNA/HIV1 RNA Mix (liquid) quality Pcr control products |
H |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-224 |
M |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-225 |
L |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-050 |
Epstein-barr virus DNA (EBV DNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-051 |
M |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-052 |
L |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-025 |
Human cytomegalovirus DNA (HCMV DNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-026 |
M |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-027 |
L |
1.00E+03～1.00E+04 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-008 |
Mycoplasma pneumoniae DNA (MP DNA) liquid indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-009 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-010 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-319 |
Chlamydia pneumonia deoxyribonucleic acid (CP DNA) liquid indoor quality Pcr control products |
L |
1.00E+03～1.00E+04 copies/mL
|
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-269 |
Human metapneumovirus RNA (HMPV RNA) Liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-270 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-271 |
L |
1.00E+03～1.00E+04 copies/mL
|
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-012 |
Gonococcal DNA (NGH DNA) liquid indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-013 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-014 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-022 |
Chlamydia trachomatis DNA (CT DNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-023 |
M |
1.00E+04～1.00E+05copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-024 |
L |
1.00E+03～1.00E+04copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-028 |
Ureaplasma urealyticum deoxyribonucleic acid (UU DNA) liquid indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-029 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-030 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-206 |
Ureaplasma microdeoxyribonucleic acid (UP DNA) liquid indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-207 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube , 20 tubes/kit |
|
|
GBDS-IQC-208 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-113 |
Chlamydia trachomatis (CT), Ureaplasma urealyticum (UU), Neisseria gonorrhoeae (NGH) DNA liquid Mixed indoor quality Pcr control products |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-114 |
L |
1.00E+04～1.00E+05 copies/mL
|
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-127 |
Mycoplasma hominis deoxyribonucleic acid (MH DNA) liquid indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-128 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-129 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-133 |
Human papillomavirus typing deoxyribonucleic acid Indoor quality Pcr control products |
M |
1.00E+05～1.00E+06 copies/mL
|
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-133-2 |
Human papillomavirus deoxyribonucleic acid (HPV DNA) mixed quality Pcr control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-133-1 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-133-3 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-016 |
Human papillomavirus type 16 DNA (HPV16 DNA) liquid indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-017 |
M |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-018 |
L |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-019 |
Human papillomavirus type 18 DNA (HPV18 DNA) liquid indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-020 |
M |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-021 |
L |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-037 |
Human papillomavirus types 16 and 18 deoxyribose nuclei Acid liquid indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-038 |
M |
1.00E+05～1.00E+06 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-039 |
L |
1.00E+04～1.00E+05 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-041 |
Human papillomavirus type 6 deoxyribonucleic acid Indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-042 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-043 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-044 |
Human papillomavirus type 11 deoxyribonucleic acid Indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-045 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-046 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-047 |
Human papillomavirus type 6, 11 DNA Liquid indoor quality Pcr control products |
H |
1.00E+06～1.00E+07 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-048 |
M |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-049 |
L |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-031 |
Herpes simplex virus type I DNA (HSV I DNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-032 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-033 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-034 |
Herpes simplex virus type II DNA (HSVⅡ DNA) liquid indoor quality Pcr control products |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-035 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-036 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
Chickenpox - herpes zoster virus DNA (VZV DNA) liquid indoor quality Pcr control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-163 |
B group Streptococcus deoxyribonucleic acid (GBS DNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-164 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-165 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-060 |
Mycobacterium tuberculosis deoxyribonucleic acid (TB DNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-059 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-058 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-063 |
Rubella virus RNA (RV RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-062 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-061 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-390 |
Measles virus RNA indoor quality Pcr control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-260 |
Rubella/measles virus ribonucleic acid mixed liquid chamber Internal quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-261 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-262 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-064 |
Enterovirus 71 RNA (EV71 RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-065 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-066 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-115 |
Enterovirus universal ribonucleic acid (EV RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-116 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-117 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-067 |
Coxsackie virus CA16 RNA (CA16 RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-068 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-069 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-217 |
Coxsackie virus CA6 RNA (CA6 RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-218 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-219 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-220 |
Coxsackie virus CA10 RNA (CA10 RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-221 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-222 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-070 |
Group A rotavirus RNA (RWA RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-071 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-072 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-226 |
Norovirus RNA (NV RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-227 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-228 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-130 |
Influenza A virus RNA (IVA RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-131 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-132 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-073 |
Influenza B virus ribonucleic acid (IVB RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-074 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-075 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-316 |
Type B fluid-sensitive nucleotide nucleoacid (IVB RNA) liquid indoor quality Pcr control products (Yamagata Plant) |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-317 |
Type B fluid-sensitive nucleotide nucleoacid (IVB RNA) Liquid indoor quality Pcr control products (Victoria Plant) |
L |
1.00E+03～1.00E+04 copies/mL
|
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-173 |
Influenza A/HIN1 viral RNA (HIN1 RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-174 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-175 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-341 |
Influenza A H3N2 viral RNA (H3N2 RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-342 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-315 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-176 |
Influenza A H5N1 viral RNA (H5N1 RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-177 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-178 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-179 |
Influenza A (H7N9) virus RNA (H7N9) RNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-180 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-181 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-182 |
Influenza A H9N2 viral RNA (H9N2 RNA) liquid indoor quality Pcr control products
|
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-183 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-184 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-281 |
Influenza A H9N2 viral RNA (H9N2 RNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-282 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-077 |
Human parainfluenza type 2 virus RNA (PIV2 RNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-078 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-080 |
Human parainfluenza 3 virus ribonucleic acid (PIV3 RNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-081 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-083 |
Human parainfluenza 4b virus RNA (PIV4b RNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-084 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-086 |
Respiratory syncytial virus type A RNA liquid Indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-087 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-230 |
Respiratory syncytial virus B RNA liquid Indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-231 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-233 |
Adenovirus DNA (ADV DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-234 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-286 |
Adenovirus type 1 deoxyribonucleic acid (ADV1 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-287 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-288 |
Adenovirus type 2 deoxyribonucleic acid (ADV2 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-289 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-264 |
Adenovirus type 3 deoxyribonucleic acid (ADV3 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-265 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-278 |
Adenovirus type 4 deoxyribonucleic acid (ADV4 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-279 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-290 |
Adenovirus type 5 deoxyribonucleic acid (ADV5 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-291 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-267 |
Adenovirus type 7 deoxyribonucleic acid (ADV7 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-268 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-292 |
Adenovirus type 11 deoxyribonucleic acid (ADV11 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-293 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-294 |
Adenovirus type 14 deoxyribonucleic acid (ADV14 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-295 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-296 |
Adenovirus type 21 deoxyribonucleic acid (ADV21 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-297 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-298 |
Adenovirus type 41 deoxyribonucleic acid (ADV41 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-299 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-300 |
Adenovirus type 48 deoxyribonucleic acid (ADV48 DNA) liquid indoor quality Pcr control products |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-301 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-088 |
Dengue virus type I RNA Liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-089 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-090 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-091 |
Dengue virus type II RNA Liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-092 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-093 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-094 |
Dengue virus type III RNA Liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-095 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-096 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-097 |
Dengue virus type IV RNA Liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-098 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-099 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-235 |
Human coronavirus HCoV-OC43 RNA Liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-236 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-237 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-238 |
Human coronavirus HCoV-HKU1 RNA Liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-239 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-240 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-241 |
Human coronavirus HCoV-229E RNA Liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-242 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-243 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-244 |
Human coronavirus HCoV-NL63 RNA Liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-245 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-246 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
Severe Acute respiratory syndrome coronavirus ribose Nucleic acid (SARS-CoV RNA) liquid chamber Quality Pcr control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-248 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-249 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-275 |
2019 Novel coronavirus RNA (2019-nCoV RNA) liquid indoor quality Pcr control product |
M S2 |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-276 |
L S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-304 |
S0 |
1.00E+02～1.00E+03 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-305 |
L1 |
500copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-367 |
L2 |
250copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-303 |
Negative |
/ |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-306 |
Novel coronavirus B.1.1.7 mutant nucleoacid Indoor quality Pcr control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-1 |
Nucleoacid of novel coronavirus B.1.351 mutant strain Body Pcr control product |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-2 |
Nuclear acid constitution of novel coronavirus P.1 mutant strain Pcr control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-3 |
Nucleoacid of novel coronavirus B.1.617 mutant strain Body Pcr control product |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-4 |
Nucleic acid of Omicron mutant strain of novel coronavirus Liquid quality Pcr control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-5 |
Nucleic acid liquid of novel coronavirus Delta mutant strain Quality Pcr control product |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-306-6 |
Mutations in the Omicron BA.2 subtype of the novel coronavirus Nucleic acid liquid quality Pcr control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-373 |
Monkeypox virus deoxyribonucleic acid liquid indoor quality Pcr control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 10 tubes/kit |
|
GBDS-IQC-374 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 10 tubes/kit |
|
|
GBDS-IQC-375 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 10 tubes/kit |
|
GBDS-IQC-383 |
Vaccinia virus nucleic acid indoor quality Pcr control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-384 |
Vaccinia virus - Tiantan strain nucleic acid indoor quality Pcr control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-385 |
Camel pox virus nucleic acid indoor quality Pcr control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-386 |
Vaccinia virus nucleic acid indoor quality Pcr control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-387 |
Light smallpox virus nucleic acid indoor quality Pcr control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-388 |
Smallpox virus nucleic acid indoor quality Pcr control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-389 |
Heavy smallpox virus nucleic acid indoor quality Pcr control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-198 |
Middle East Respiratory Syndrome coronavirus (MERS) nuclear Sugar nucleic acid liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-199 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-200 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-255 |
Zika virus RNA liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-256 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-257 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-318 |
Human rhinovirus RNA (HRV RNA) solution Indoor quality Pcr control products |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-343 |
Legionella pneumophila DNA liquid chamber Quality Pcr control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-344 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-320 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-345 |
Staphylococcus aureus deoxyribonucleic acid (SA DNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-346 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-322 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-347 |
Candida albicans DNA liquid chamber Quality Pcr control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-348 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-323 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-349 |
Candida albicans deoxyribonucleic acid (CG DNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-350 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-324 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-351 |
Pertussis bacteria deoxyribonucleic acid liquid chamber Quality Pcr control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-352 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-325 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-353 |
Klebsiella pneumoniae deoxyribonucleic acid (KP DNA) liquid indoor quality Pcr control products |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-354 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-326 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-355 |
Pneumococcal DNA liquid chamber Quality Pcr control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-356 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-327 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-357 |
The internal deplasticized oxygen Pcr control nucleosaccharide nucleic acid liquid chamber of Streptococcus pyogenes |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-358 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-328 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-359 |
Haemophilus influenzae deoxyribonucleic acid liquid indoor quality Pcr control |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-360 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-329 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-361 |
Escherichia coli deoxynucleated sugar Pcr control product nucleic acid liquid indoor quality |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-362 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-331 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-363 |
Listeria deoxynucleated sugar Pcr control product nucleic acid liquid indoor quality |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-364 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-332 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-365 |
Salmonella deoxynucleated sugar Pcr control nucleic acid liquid indoor substance |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-366 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-333 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-376 |
Helicobacter pylori DNA liquid chamber Quality Pcr control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-377 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-378 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-379 |
Pseudomonas aeruginosa DNA liquid chamber Quality Pcr control product |
H |
1.00E+05～1.00E+06 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-380 |
M |
1.00E+04～1.00E+05 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-381 |
L |
1.00E+03～1.00E+04 copies/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-IQC-054 |
α Genetic diagnosis of thalassemia Positive quality Pcr control products |
Optional genotypes |
-α 3.7 /αα； -α 4.2 /αα； -SEA/αα；-SEA/-α 3.7； -SEA/-α 4.2；-α 3.7 /-α 4.2, etc. |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-055 |
β Genetic diagnosis of thalassemia Positive quality Pcr control products |
Optional genotypes |
β -28 /β N； β CD17 /β N；β CD41-42 /β N；β IVS-2-654 /β N；β CD26 /β N；etc. |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-056 |
α / β Thalassemia gene diagnosis normal quality Pcr control products |
Normal person |
Whole blood, αα/αα; β / β |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-100 |
Noninvasive prenatal genetic testing: 21, 13, 18 Quality Pcr control for liquid with abnormal number of chromophores |
21, 13, 18 staining trisomy |
21, 13, 18 staining trisomy |
0.7mL/ tube, 10 tubes/kit |
|
GBDS-IQC-101 |
Noninvasive prenatal genetic testing: 21, 13, 18 Number of normal liquid quality Pcr control products |
Normal quality Pcr control product |
Different chromosomes are optional |
0.7mL/ tube, 10 tubes/kit |
|
GBDS-IQC-254 |
Deafness gene dry blood spot (DBS) quality Pcr control products |
Dry blood spot |
12 genes for deafness |
6 Blood spots/kit |
|
GBDS-IQC-382 |
Metagenomic sequencing quality Pcr control products |
S1 |
1.00E+03～1.00E+04 copies/mL |
1ml/tube，5 tube/kit |
|
GBDS-IQC-103 |
CYP2C19 gene test quality Pcr control product |
Liquid |
CYP2C19*2、CYP2C19*3、CYP2C19*17 |
5 tube/kit |
|
GBDS-IQC-104 |
Folate metabolic capacity (MTHFR) Genotyping whole blood quality Pcr control product |
Optional genotypes |
MTHFR Gene |
5 tube/kit |
|
GBDS-IQC-105 |
CYP3A5 gene test quality Pcr control product |
Liquid |
CYP3A5 gene |
5 tube/kit |
|
GBDS-IQC-106 |
ROS1 gene test quality Pcr control product |
Liquid |
ROS1 gene |
5 tube/kit |
|
GBDS-IQC-107 |
PIK3CAGene mutation quality Pcr control products |
Liquid |
PIK3CA gene mutation |
5 tube/kit |
|
GBDS-IQC-108 |
EGFR Gene mutation quality Pcr control products |
Liquid |
EGFR gene mutation |
5 tube/kit |
|
GBDS-IQC-109 |
KRAS gene mutation quality Pcr control products |
Liquid |
KRAS gene mutation |
5 tube/kit |
|
GBDS-IQC-110 |
BRAF gene mutation quality Pcr control products |
Liquid |
BRAF gene mutation |
5 tube/kit |
|
GBDS-IQC-302 |
ALK gene mutation quality Pcr control products |
Liquid |
ALK gene mutation |
5 tube/kit |
|
GBDS-IQC-201 |
BRCA gene mutation quality Pcr control products |
Liquid |
BRCA gene mutation |
5 tube/kit |
|
GBDS-IQC-202 |
TP53 gene mutation quality Pcr control products |
Liquid |
TP53 gene mutation |
5 tube/kit |
|
GBDS-IQC-111 |
CYP2C9 and VKORC1 gene detection of warfarin Test quality Pcr control products |
Liquid |
CYP2C9 and VKORC1 gene |
5 tube/kit |
|
GBDS-IQC-147 |
Phenylketonuria gene dry blood spot (DBS) quality Pcr control product |
Dry blood spot |
4r kinds of PAH genes |
6 Blood spots/kit |
|
GBDS-IQC-258 |
Human acetaldehyde dehydrogenase 2(ALDH2) gene is abundant State test quality Pcr control products |
Liquid |
ALDH2; c.1510G/A, heterozygous mutation |
5 tube/kit |
|
GBDS-IQC-259 |
Polypeptide of human SLCO1B1 and ApoE genes Check quality Pcr control products |
Liquid |
SLCO1B1*1b，SLCO1B1*5、 ApoE2、ApoE4 |
5 tube/kit |
|
GBDS-IQC-203 |
Human HLA-B27 gene whole blood quality Pcr control product |
Whole blood |
HLA-B27 Positive |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-204 |
Leukemia AML1-ETO fusion gene quality Pcr control products |
Liquid |
AML1-ETO fusion |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-205 |
Leukemia PML-RARA fusion gene quality Pcr control product |
Liquid |
PML-RARA fusion |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-251 |
Leukemia BCR-ABL1 fusion gene quality Pcr control product |
Liquid |
BCR-ABL1 fusion |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-285 |
Serum/plasma negative quality Pcr control products |
Negative |
Suitable for HBV DNA/HCV RNA/HIV1 RNA/TP DNA and other serum varieties were negative Quality Pcr control |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-161 |
Negative quality Pcr control products |
Negative |
Applicable to UU DNA/CT DNA/ NGH Negative quality Pcr control of DNA and other cultured varieties |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-IQC-151-1 |
HPV negative quality Pcr control products |
Negative |
It is suitable for the negative nature of all types of human papilloma Pcr control; Human genome containing |
0.5mL/ tube, 20 tubes/kit |
2. Immune indoor quality Pcr control products
|
Number |
Name |
Concentration Serial |
Standard Value |
Specification |
|
GBDS-I-217 |
Novel Coronavirus (SARS-CoV-2) Antigen quality Pcr control products |
/ |
Positive |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-I-218 |
Novel Coronavirus (SARS-CoV-2) IgG/IgM antibody quality Pcr control product |
/ |
Positive |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-I-001 |
Hepatitis B virus surface antigen (HBsAg) serum (liquid) indoor Quality Pcr control product |
S1 |
0.1 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-I-002 |
S2 |
0.2 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-003 |
S3 |
0.5 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-004 |
S4 |
5.0 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-005 |
S5 |
25.0 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-006 |
Hepatitis B virus surface antibody (HBsAb) serum (liquid) indoor Quality Pcr control product |
S1 |
5 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-I-007 |
S2 |
10 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-008 |
S3 |
25 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-009 |
S4 |
50 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-010 |
S5 |
100 IU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
Hepatitis B virus e antigen (HBeAg) serum (liquid) indoor Quality Pcr control product |
S1 |
1.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-012 |
S2 |
2.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-013 |
S3 |
4.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-014 |
Hepatitis B virus e antibody (HBeAb) serum (liquid) indoor Quality Pcr control product |
S1 |
1.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-I-015 |
S2 |
2.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-016 |
S3 |
4.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-017 |
S4 |
8.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-018 |
Hepatitis B virus core antibody (HBcAb) serum (liquid) indoor Quality Pcr control product |
S1 |
0.5 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-I-019 |
S2 |
1.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-020 |
S3 |
1.5 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-021 |
S4 |
2.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-036 |
Human immunodeficiency virus Type 1 antibody (anti-HIV-1) Serum (liquid) indoor quality Pcr control products |
L1 |
0.2 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-I-035 |
S0 |
0.5 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-022 |
S1 |
1.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-023 |
S2 |
2.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-024 |
S3 |
4.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-025 |
S4 |
8.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-219 |
Antibodies to hepatitis C virus (anti-HCV) serum (fluid) chamber Internal quality Pcr control products |
L2 |
0.03 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-I-220 |
L1 |
0.05 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-034 |
S0 |
0.5 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-026 |
S1 |
1.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-027 |
S2 |
2.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-028 |
S3 |
4.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-029 |
S4 |
8.0 NCU/mL |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-030 |
Antibody to Treponema pallidum (anti-TP) Serum (liquid) indoor quality Pcr control products |
S1 |
3.0 mIU/ml |
0.5mL/ tube, 20 tubes/kit |
|
GBDS-I-031 |
S2 |
6.0 mIU/ml |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-032 |
S3 |
12 mIU/ml |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-033 |
S4 |
18 mIU/ml |
0.5mL/ tube, 20 tubes/kit |
|
|
GBDS-I-133 |
Prenatal screening indoor quality Pcr control products |
S1 |
L |
1.0mL/ bottle, 9 bottles/kit |
|
GBDS-I-134 |
S2 |
M |
1.0mL/ bottle, 9 bottles/kit |
|
|
GBDS-I-135 |
S3 |
H |
1.0mL/ bottle, 9 bottles/kit |
|
|
GBDS-I-136 |
Neonatal screening indoor quality Pcr control products |
S1 |
L |
2 blood spots/set, 3 sets/kit |
|
GBDS-I-137 |
S2 |
M |
（1）G6PD blood spot （2）TSH\Phe\17-OHP |
|
|
GBDS-I-213 |
S3 |
H |
||
|
GBDS-I-152 |
A variety of amino acids, carnitine and succinylpropyl Ketone indoor quality Pcr control products |
C1 |
L |
There were 5 blood spots in C1 and C2 respectively, 10 Blood spot/set, 1 set/kit |
|
C2 |
H |
|||
|
GBDS-I-210 |
Indoor quality Pcr control product for immune serum (dry powder) |
S1 |
L |
5.0mL/ bottle, 6 bottles/kit |
|
GBDS-I-211 |
S2 |
M |
5.0mL/ bottle, 6 bottles/kit |
|
|
GBDS-I-212 |
S3 |
H |
5.0mL/ bottle, 6 bottles/kit |
Our Run controls are used in follwing instruments:
-
1drop Inc. - 1drop Inc. 1copy NAT qPCR 4plex
AB Analitica - AB Analitica RQ ABFlu-CoV-2
AB Analitica - AB Analitica RQ Resp/ABFlu-CoV-2
AB Analitica ● AB Analitica RQ Pcr
Abacus Diagnostica
Abacus Diagnostica - Abacus Diagnostica NAT IVDR
Abbott - Abbott Alinity m
Abbott - Abbott ID NOW
Abbott ● Abbott Alinity NAT IVDR● Abbott ID NOW NAT
Adaltis
AITbiotech
AITbiotech - AITbiotech abTES NAT
Algimed Techno
Algimed Techno - Algimed Alsense NAT IVDR
Altona Diagnostics
AMT
AMT - AMT Resolute NAT IVDR
Anatolia Geneworks
ArtBioTech
ArtBioTech - ArtTest NAT
Astra Biotech
Astra Biotech - Astra Biotech NAT IVDR
AusDiagnostics - AusDiagnostics Respiratory Viruses
AusDiagnostics ● AusDiagnostics Respiratory Pathogens
BD Molecular Diagnostics - BD SARS-CoV-2/Flu
BD Molecular Diagnostics ● BD NAT IVDR
BGI
Biocartis
Biocartis - Biocartis Idylla NAT IVDR
Bioeksen
Bioeksen - Bioeksen Biospeedy NAT IVDR
Bioer Technologies
Bioline
Bioline - Bioline SensiFast
BioMaxima
BioMaxima - BioMaxima NAT IVDR
bioMerieux - bioMerieux R-gene NAT IVDR
Bioneer
Bio-Rad
Bio-Rad - Bio-Rad NAT IVDR
Bosch
Bosch - Bosch Vivalytic NAT IVDR
CDC
CDC - CDC NAT IVDR
Cepheid - Cepheid Xpert carba-r
Cepheid ● Cepheid Xpert NAT IVDR
Certest - Certest Viasure NAT IVDR& UK Variant (S UK
Certest - Certest Viasure S
Certest - Certest Viasure SCV2/FLU/RSV
Certest ● Certest Viasure N1 + N2 ● Certest Viasure ORF1 & N
Clonit
Clonit - Clonit NAT HT Screen
CO-Diagnostics.Inc
CO-Diagnostics.Inc - Co-Diagnostics Inc Logix Smart
Coyote Bioscience
Coyote Bioscience - Coyote Bioscience NAT IVDR
Credo Diagnostics Biomedical
DAAN GENE
DIaCarta
DIaCarta - DiaCarta QuantiVirus PCR kit
DiagCor
DiagCor - DiagCor GenoScreen NAT IVDR
Diagenode
Diagenode - Diagenode Real-Time PCR
Diana Biotechnologies
Diana Biotechnologies - Diana Biotechnologies NAT
DiaPro
DiaPro - DiaPro NAT
DiaSorin
Diatheva
Diatheva - Diatheva NAT
DNA-Technology Russia
DNA-Technology Russia - DNA-Technology NAT
DRW
ELITech Group ● Elitech Elite Real Time kit ● Elitech GeneFinder NAT
Eurobio Scientific
Eurobio Scientific - EurobioPlex NAT IVDR
Eurofins
Eurofins - Eurofins ViroBOAR
EUROIMMUN
EUROIMMUN - EURO RealTime NAT IVDR
FMBA
FMBA - FMBA AmpliTest NAT IVDR
GeneFirst
GeneFirst - GeneFirst NAT
Genematrix
Genematrix - Genematrix NeoPlex
Genestore
Genestore - Genestore NAT PCR
Genetic Signatures
Genetic Signatures - Genetic Signatures NAT IVDR
GenMark Dx - GenMark GeneMAP Pcr (SARS-CoV-2)
Genrui Biotech Inc.
Genrui Biotech Inc. - Genrui Novel Coronavirus Detection Kit
Gensutek
Gensutek - Gensutek NAT IVDRqPCR
Gensutek - Gensutek NAT qPCR
Gerbion - Gerbion virella NAT IVDR
Grifols
Grifols - Grifols Procleix NAT IVDR
Hain Lifescience
Hain Lifescience - Hain Lifescience NAT IVDRplus
Hain Lifescience - Hain Lifescience SARS-CoV
Hema Diagnostic Systems
Hema Diagnostic Systems - Hema NAT
Hybribio Limited
Hybribio Limited - Hybribio Real-Time PCR Kit
IDT
IDT - IDT N1+N2
Imegen
Imegen - Imegen NAT IVDR
Imegen - Imegen NAT IVDRPlus
In-House - Conventional In-House PCR
IONTEK
IONTEK - IONTEK Fluorion qPCR
Jiangsu Bioperfectus technologies
Jiangsu Bioperfectus technologies - Jiangsu Bioperfectus technologies NAT
Krosgen
Krosgen - Krosgen KrosQuanT NAT IVDR
Labsystems Diagnostics
Labsystems Diagnostics - Labsystems Diagnostics NAT
LabTurbo
LabTurbo - LabTurbo NAT
LGC Biosearch Technologies
LGC Biosearch Technologies - LGC UltraDx NAT IVDR
Ltd - Shanghai KHB NAT IVDR
Luminex - Luminex NxTAG RPP + SCV2
Maccura Biotechnology
Maccura Biotechnology - Maccura NAT IVDR
Medicofarma
Medicofarma - Medicofarma MediPAN COVID NAT IVDR
Menarini Diagnostics
Menarini Diagnostics - Menarini NAT IVDR
Mikrogen
Mikrogen - Mikrogen ampliCube Coronavirus/SCV2
MiRXES
MiRXES - MiRXES Fortitude NAT
Mobidiag - Mobidiag Amplidiag NAT
Molbio Diagnostics
Molbio Diagnostics - Molbio Diagnostics Truenat SCV2
NEB - NEB Luna NAT IVDR
NEB - NEB NAT IVDR
Nuclear Laser Medicine
Nuclear Laser Medicine - Nuclear Laser NAT IVDR
NZYTech
NZYTech - NZYTech NAT IVDR
ORF1ab and N genes)
Oxford Nanopore
Oxford Nanopore - Oxford Nanopore LamPORE NAT
PathoFinder - PathoFinder RealAccurate SCV-2
PathoFinder - PathoFinder RespiFinder 2SMART
PentaBase
PentaBase - PentaBase CoviDetect
Phase Scientific
Phase Scientific - Phase Scientific NAT
PrimerDesign - PrimerDesign PROmate
Procomcure Biotech
Procomcure Biotech - Procomcure Biotech PhoenixDx NAT IVDR
Promega
Promega - Promega NAT IVDR
QIAGEN - QIAGEN Artus Real Time
QIAGEN - Qiagen QIAstat-Dx SCV2
Q-Sens
Q-Sens - Q-Sens COVID19
QuantuMDx
QuantuMDx - QuantuMDx SARSCoV-2
R-Biopharm
R-Biopharm - R-Biopharm RIDA Gene FLU & SARS
R-Biopharm - R-Biopharm RIDA Gene SCV2
Roche - Roche Cobas NAT IVDR
Sacace
Sacace - Sacace NAT IVDR
Savyon Diagnostics
Savyon Diagnostics - Savyon Savvygen NAT IVDR
Seegene - Seegene Allplex SCV2/Flu/RSV
Serosep
Serosep - Serosep RespiBio NAT IVDR
Shanghai Fosun Pharmaceutical
Shanghai Fosun Pharmaceutical - Shanghai Fosun Real Time PCR
Shanghai Kehua bio engineering Co.
Siam Bioscience
Siam Bioscience - Siam Bioscience NAT IVDR
SIMITECNO
SIMITECNO - SIMITECNO NAT IVDR
Singuway Biotech Inc
Singuway Biotech Inc - Singuway Biotech NAT
Snibe Diagnostic
Snibe Diagnostic - Snibe Diagnostic NAT IVDR
SolGent
SolGent - SolGent DiaPlexQnCoV
Tianlong
Tianlong - Tianlong NAT
TK Biotech
TK Biotech - TK Biotech NAT IVDR
USTAR
USTAR - USTAR EasyNat NAT IVDR
Vazyme
Vazyme - Vazyme NAT IVDR
Vitassay - Vitassay SCV2/Flu
Yourgene Health
Yourgene Health - Yourgene Health Clarigene NAT IVDR